Last update 19 Jul 2025

Furazolidone

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
3-(5'-Nitrofurfuralamino)-2-oxazolidone, 3-[(5-Nitrofurfurylidene)amino]-2-oxazolidinone, 3-[(5-Nitrofurfurylidene)amino]-2-oxazolidone
+ [10]
Target
Action
inhibitors
Mechanism
DNA inhibitors(DNA inhibitors)
Active Indication
Inactive Indication-
Originator Organization
Inactive Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
United States (20 Jan 1958),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC8H7N3O5
InChIKeyPLHJDBGFXBMTGZ-UHFFFAOYSA-N
CAS Registry67-45-8

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Cholera
China
01 Jan 1981
Dysentery
China
01 Jan 1981
Giardiasis
China
01 Jan 1981
Trichomonas Infections
China
01 Jan 1981
Typhoid Fever
China
01 Jan 1981
Enteritis
United States
20 Jan 1958
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
-
Bismuth quadruple regimen containing furazolidone and tetracycline
ificodndbh(sjinxvhhkx) = 6.3% mmuttvaicm (babweifvvf )
-
09 Oct 2022
Not Applicable
-
-
ncimgwutwb(oyxwvpzcel) = 3.7% wylwoxjsyu (ihgoqbdjsd )
-
09 Oct 2022
Not Applicable
-
-
qkogncpvkb(gajedqubtn) = Frequencies of adverse events in F-BQT and C-BQT had no differences (36.0% in C-BQT vs 32.6% in F-BQT, P = 0.499) lrsshkzckb (ulqjjzoiaj )
Positive
01 Sep 2021
Not Applicable
-
-
skalubeyjm(rgoxndzbyd) = crgaoyuezj fwoqinclag (uscaiycfyt, 94–96)
-
01 Oct 2018
Not Applicable
-
-
OABF
wvjygojxqa(cblpjzvdsa) = more frequently in group C (OAF) with p<0.05 qmzxdxpeqb (dvodqayrzx )
-
01 Oct 2013
OABM-F
Not Applicable
176
Triple therapy
pxzfkzwkmw(swklljspwq) = jusryicemm bugkvacpob (bapxkukspr )
-
01 Sep 2009
Furazolidone, Co-amoxiclav, Colloidal Bismuth Subcitrate, and Esomeprazole
pxzfkzwkmw(swklljspwq) = jpweubcipe bugkvacpob (bapxkukspr )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free